Canadian Life and Health Insurance Industry submission on Access to Prescription Drugs in New BrunswickRelease Date: 07/24/2015 Staff Reference: Joan Weir
Re: Canadian Life and Health Insurance Industry submission on Access to Prescription Drugs in New Brunswick
On behalf of the Canadian Life and Health Insurance Association Inc. (CLHIA) I want to thank you for the opportunity to provide input to the Discussion Paper published by the Department of Health in June 2015.
The CLHIA, established in 1894, is a voluntary association with member companies which account for 99 per cent of Canada's life and health insurance business. In New Brunswick, at the end of 2013, the life and health insurance industry provided approximately 480,000 New Brunswick residents with prescription drug coverage and made payments of about $280 million, representing approximately 72% of all prescription drug purchases in the province. Accordingly, we believe that the private payer market is a critical stakeholder in any drug reform initiative.
General Overview and Comments
The June 2015 Discussion Paper seeks ideas and input to develop a better model for the government prescription drug plan that provides New Brunswickers with access to prescription drugs at a reasonable cost. Any changes to the current system in New Brunswick will have important implications for private payers and we look forward to a continued dialogue with the province as you formalize the options for reform. We would be very interested in an opportunity to meet with officials to share our detailed feedback on any proposed options at the appropriate time.